Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,540.00 9.00 (0.59%)

Bid:

1,535.00

Ask:

1,536.00

Spread: 1.00 (0.065%)

Market Cap: £3.24b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Hikma Pharmaceuticals News

Hikma Pharmaceuticals Guides For Growth In 2016 As Profit Falls

Currency headwinds push Hikma Pharmaceuticals profits down

(ShareCast News) - Drug group Hikma Pharmaceuticals reported revenue of $1.44bn (£1.02bn) in its final results for 2015 on Wednesday, down 3% on what ...

Earnings, Trading Statements Calendar - Week Ahead

Sports Direct to drop out of FTSE 100 in reshuffle

* WM Morrison, Paddy Power and Betfair to join FTSE 100 * Informa and Mediclinic to also join FTSE 100 * Sports Direct, Aberdeen AM, Smiths, Hikma dro...

Paddy Power Betfair, Mediclinic, Informa And Morrisons Join FTSE 100

Morrisons set for FTSE 100 return, Sports Direct in line for demotion

(ShareCast News) - Morrisons, which announced a new grocery supply deal with Amazon.com on Monday, may work its way back into the FTSE 100 this month....

U.S. sets conditions for Hikma's takeover of Boehringer's Roxane

WASHINGTON, Feb 26 (Reuters) - Drug manufacturer Hikma Pharmaceuticals Plc will sell the rights and assets of two generic drugs and relinquish its U.S...

Hikma hires well-connected American

(ShareCast News) - Hikma Pharmaceuticals has appointed US public affairs veteran John Castellani to its board. The FTSE 100 pharmaceuticals company sa...